Tumor cells can evade the immune response by losing the expression of tumor antigens and/or actively inhibiting the responses of effector cells via inhibitory ligands, such as CTLA-4 and PD-L1 (Davoli et al. 2017; Juneja et al. 2017). The gene discussed is CTLA4; the disease is neoplasm.